Pricing

>

Latest News

FDA Grants Interchangeability Designation to Celltrion’s Humira Biosimilar Yuflyma
FDA Grants Interchangeability Designation to Celltrion’s Humira Biosimilar Yuflyma

April 17th 2025

The interchangeability designation for Yuflyma, a biosimilar to Humira, may help to improve patient access and reduce costs.

Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit
Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit

April 10th 2025

US Drug Price Negotiations and Transparency
US Drug Price Negotiations and Transparency

April 9th 2025

Maintaining R&D Investments in the IRA Era
Maintaining R&D Investments in the IRA Era

April 8th 2025

Trump Signs Healthcare Price Transparency Executive Order
Trump Signs Healthcare Price Transparency Executive Order

February 26th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.